A birth control pill designed for men that temporarily pauses the production of sperm, with no hormones required, has passed its first safety trial. The landmark birth control pill is spurring ...

An experimental, hormone-free male birth control pill has just passed its first safety test in humans. The trial included 16 people and was only intended to test whether the drug reached adequate ...

GRACE AIGNER: Hi everyone! I’m Grace Aigner from the Minnesota Daily. Welcome back to another episode of In The Know, a podcast dedicated to the University of Minnesota. In my last episode, we talked ...

A molecular switch that “supercharges” sperm could inspire new safe methods of contraception—including a non-hormonal male birth control pill—and improved infertility treatments. This is the discovery ...

Nearly every Republican senator signed a letter Thursday urging the Food and Drug Administration (FDA) to reverse its decision to approve a “generic” version of the abortion pill mifepristone, which ...

Oct 15 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage trials, the company said on Wednesday ...

The Food and Drug Administration approved Evita Solutions’ generic mifepristone tablets, just before the government shutdown, per a CNBC report. The report noted that the drug is the second generic ...

A new study presented at the American Heart Association’s Hypertension Scientific Sessions 2025 has shown that a new drug called baxdrostat may help control blood pressure and protect the kidneys ...

A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications. In a recent study, the drug lowered blood pressure and also seemed to ...

A major discovery has paved the way for a male contraceptive pill, say scientists. The molecular “switch” that "supercharges" sperm for their final sprint to an egg has been pinpointed by American ...

FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly's experimental ...